Oxytetracycline and Flunixin Meglumine Injection For veterinary use only
Composition
Each ml contains Oxytetracycline 100mg and Flunixin meglumine 2mg.
Indications
For the control and treatment of infectious diseases of cattle caused by or associated with organisms sensitive to oxytetracycline, where concurrent analgesic, anti-inflammatory, anti-endotoxic or antipyretic therapy is desired. The product is especially indicated for the treatment of respiratory disease (particularly that associated with Mannheimia and Pasteurella infection) and acute mastitis (in conjunction with appropriate intramammary therapy).
Dosage and administration
For intramuscular injection.
Cattle: 1 ml/10 kg body weight daily for up to 5 days.
Adverse raction
Prolonged use of NSAIDs, including flunixin, may predispose or lead to gastrointestinal ulceration.
Reports of adverse reactions associated with oxytetracycline administration include injection site swelling, restlessness, ataxia, trembling, swelling of eyelids, ears, muzzle, anus and vulva (or scrotum and sheath in males), respiratory abnormalities (labored breathing), frothing at the mouth, collapse and possibly death. Some of these reactions may be attributed either to anaphylaxis (an allergic reaction) or to cardiovascular collapse of unknown cause.
Special warnings
Do not administer other NSAIDs concurrently or within 24 hours of each other.
Do not inject more than 20 ml intramuscularly at a single site.
Withdrawal period
Meat: 21 days.
Do not use in cattle producing milk for human consumption.
Storage
Seal and protect from light.
Keep out of reach of children.
Packing
50ml/100ml/bottle
Shelf life
3year
Veterinary Medicine GMP Certificate, Veterinary Medicine Production License
Quality Management System ISO9001, Environmental Management System ISO14001, Health Management System ISO45001
Model Unit of International Cooperation in Hebei Province
Top 30 Veterinary Medicine Enterprises in Hebei Province
Top 10 Veterinary Medicine Export Enterprises in Hebei Province
Audited Supplier
